Epirubicin approved for breast cancer treatment.
Miller
J L
JL
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D015251:Epirubicin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin